Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Urinary Bladder Neoplasms 2 Hyperthermia 2 Breast Neoplasms 2 Uveal Melanoma 1 Ureteral Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Retinoblastoma 1 Prostatic Neoplasms 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

Carboplatin 23 Etoposide 19 Vincristine 16 Melphalan 13 Filgrastim 13 Topotecan 10 Granulocyte Colony-Stimulating Factor 9 Cyclophosphamide 8 Thiotepa 7 Cryotherapy 7 Peripheral Blood Stem Cell Transplantation 4 Mesna 4 Drug Therapy 4 Doxorubicin 3 Busulfan 3 Brachytherapy 3 Temozolomide 2 Radiotherapy 2 Platinum Compounds 2 Magnetic Resonance Imaging 2 Ifosfamide 2 Eye Enucleation 2 Cisplatin 2 Blood Specimen Collection 2 trioctyl phosphine oxide 1 sargramostim 1 pembrolizumab 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 omburtamab I-131 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Retinoblastoma × Hyperthermia, Induced × Clear all

NCT04681417 2025-11-28

RETINO 2018

Institut Curie

Phase 2/3 Recruiting

Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡